医学
泌尿生殖系统
更年期
药方
妇科
绝经后妇女
重症监护医学
性器官
内科学
遗传学
药理学
生物
作者
Shanice Cox,Ryan Nasseri,R Rubin,Yahir Santiago‐Lastra
标识
DOI:10.1016/j.mcna.2022.10.017
摘要
Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital health. Despite the importance of early detection and treatment , the condition is consistently underdiagnosed and undertreated. Herein, we emphasize how to diagnose GSM in postmenopausal, hypoestrogenic, and hypoandrogenic women and summarize evidence-based treatments focusing on prescription treatments and adjunctive therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI